Ceruvia Lifesciences researches, develops, and manufactures neurotransformational medicines to deliver meaningful relief to patients suffering from challenging, hard-to-treat headaches and psychiatric disorders. Since 2017, Ceruvia Lifesciences, founded by Carey Turnbull, has relentlessly focused on the discovery, development, and commercialization of psychedelic medicines to deliver meaningful relief to patients suffering from cluster headaches, hard-to-treat headache disorders and OCD.